Luigi Tarantini

9PUBLICATIONS
36CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 27, 2026
Cardiovascular Toxicity of BTK Inhibitors: A Patient-Centered Framework for Risk Stratification and Management.

|Jul 28, 2026
Integrating Nutrition and Exercise to Mitigate Cardiometabolic Risk and Enhance Outcomes in Lung Cancer During the Era of Immunotherapy and Targeted Therapy.

|Nov 13, 2025
A New Era, New Risks: The Cardio-Oncology Perspective on Immunotherapy in Non-Small Cell Lung Cancer.

Luigi Tarantini, Giuseppina Gallucci, Alessandro Inno

|Sep 27, 2025
Long-Term Cardiovascular Toxicity of Immunotherapy: Too Important to Ignore.

Andrea Camerini, Alessandro Inno, Maria Laura Canale

|Jan 11, 2025
Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 Management.

Giuseppina Gallucci, Mario Larocca, Alessandro Navazio

|Aug 29, 2024
Addressing Post-Acute COVID-19 Syndrome in Cancer Patients, from Visceral Obesity and Myosteatosis to Systemic Inflammation: Implications in Cardio-Onco-Metabolism.

Vincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia

Pageof 2

Frequent Collaborators

8 joint publications

Alessandro Navazio

6 joint publications

Carmine Pinto

6 joint publications

Alessandro Inno

3 joint publications

Andrea Tedeschi